知镜 Cognispect · 医学文献与研究工作台

Sleep and Stroop Performance with Adjunctive Melatonin in Pharmacotherapy-stable Pediatric ADHD: A Prospective Open-label Study.

Tripathi R, Singh S, Arya A, Agarwal V.
Indian journal of psychological medicine · 2026-08-18 · PMID 42620628

文献摘要

Background Attention-deficit/hyperactivity disorder (ADHD) is frequently comorbid with sleep disturbances; evidence linking melatonin to objective neurocognitive outcomes in this population is lacking. The present study assessed the association of melatonin with parent-reported sleep disturbance scores and Stroop Color-Word Test performance in children and adolescents with ADHD and comorbid sleep disturbances on stable pharmacotherapy. Methods Prospective, open-label, single-arm, 6-week study. Thirty-three participants (ADHD; Children's Sleep Habits Questionnaire [CSHQ] score ≥41) on stable methylphenidate or atomoxetine were enrolled; 32 completed follow-up. Melatonin (3 mg/day t tests. Results Total CSHQ scores declined from 50.25 ± 3.60 to 34.31 ± 2.69 at 6 weeks ( F =506.238, p η ²=0.942), with significant improvement in six of eight subscales after Bonferroni correction. Pre- and post-Stroop scores showed large observed changes ( d =1.12-1.19; all p r =0.19-0.29; p > .10). Adverse effects were mild and transient. Conclusions Pre- and post-improvements in parent-reported sleep scores and Stroop performance were observed over 6 weeks of melatonin use; given the single-arm design, causal attribution is not possible. Randomized controlled trials with objective sleep measures and parallel cognitive assessment forms are warranted.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。